Acrivon Therapeutics Inc (ACRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Operating Expenses | 14,393 | 9,945 | 9,575 | 5,925 | 7,212 |
Operating Income | -14,393 | -9,945 | -9,575 | -5,925 | -7,212 |
Other Income | 1,637 | 1,016 | 377 | 105 | -8 |
Pre-tax Income | -12,756 | -8,929 | -9,198 | -5,820 | -7,220 |
Net Income Continuous | -12,756 | -8,929 | -9,198 | -5,820 | -7,220 |
Net Income | $-12,756 | $-8,929 | $-9,198 | $-5,820 | $-7,220 |
EPS Basic Total Ops | -0.58 | 4.98 | -5.17 | -3.29 | -4.08 |
EPS Basic Continuous Ops | -0.58 | 4.98 | -5.17 | -3.29 | -4.08 |
EPS Diluted Total Ops | -0.58 | 4.98 | -5.17 | -3.29 | -4.08 |
EPS Diluted Continuous Ops | -0.58 | 4.98 | -5.17 | -3.29 | -4.08 |
EPS Diluted Before Non-Recurring Items | -0.58 | -0.80 | -5.17 | N/A | N/A |
EBITDA(a) | $-15,401 | $-10,336 | $-9,641 | $-5,847 | $-7,167 |